MARKET ACCESS & HEALTHCARE AFFAIRS MANAGER
BRIEF COMPANY PROFILE
A Successful and Family-owned Company
With a pioneering history and celebrating 135 years of heritage, Boehringer Ingelheim marks its global presence as one of the pharmaceutical industry’s top 20 companies and as a global leader in biopharmaceuticals.
Founded in 1885 by Albert Boehringer (1861-1939) in Ingelheim am Rhein, Germany, Boehringer Ingelheim started out as a small tartar factory, employing just 28 people, that manufactured chemical compounds used by pharmacies and dyeing works. Within its first few years, the business surged as demand increased. In 1893, Boehringer made the ground-breaking discovery that lactic acid can be produced in mass quantities by means of bacteria. This revelation allowed the company to move into large-scale "biotech" production and by the time of Albert Boehringer’s death in 1939, the company employed 1,500 people and was the leading manufacturer of lactic acid.
To this day, the Boehringer family continues to lead the company with the innovative research-driven focus to fill the unmet treatment needs of patients with cardiovascular diseases, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology.
As a global, family-owned business, Boehringer Ingelheim combines the ambitious spirit of its pioneer, continuously looking for opportunities to grow, with the care of the family, always putting people at the heart of everything they do.
Headquartered in Ingelheim am Rhein, Germany, the global enterprise of Boehringer Ingelheim today employs more than 51,000 employees and provides the entire value chain, from research to manufacturing for the three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
The Danish office is located in Copenhagen and is the home of around 200 dedicated employees within Human Pharma and Animal Health.
As an independent, family-owned business, the key focus at Boehringer Ingelheim is on long-term, sustainable action. To achieve this goal requires sound financing and organic corporate growth.
As a world-leading, research-driven pharmaceutical company, Boehringer Ingelheim achieved net sales of 19 billion euros in 2019 with significant investments of almost 3.5 billion euros in R&D driving innovation and enabling the next generation of medicines that save lives and improve quality of life.
The Market Access & Healthcare Affairs Manager will lead the national and regional market access strategies to introduce Jardiance® as a treatment for heart failure and ensure its appropriate listing in the regional healthcare system. Hence, by building a solid platform of clinical, health economic, and RW evidence, the role will be responsible for strengthening the Jardiance® market access platform by collaborating with 3rdparty interest groups and informing key stakeholders about the unmet needs of patients with heart failure.
The role will have a real impact on the care and prognosis of patients suffering from heart failure through generating and communicating evidence, negotiating, and building relations with key stakeholders such as regional payers, healthcare committees, scientific associations, and patient organizations. Further, as a key communicator, the role will lead the collaboration efforts with clinical pharmacologists and formulary committees to ensure the appropriate listing of Jardiance® in heart failure.
The ideal candidate for this position brings solid experience from the Danish regional payer system, generated from either the Pharmaceutical industry and/or Danish regional/national payers and/or national policy makers.
The role will represent market access in the Heart Failure Brand Team and provide training to the team and other key stakeholders, to ensure a solid understanding of local payer markets and emerging stakeholders in the reimbursement area as well as determine appropriate responses to elevate patient care.
Market Access & Healthcare Affairs Manager
Head of Market Access & Public Affairs
Mainly in Denmark
Responsibilities & Tasks:
Leading the national and regional market access strategy and execution for heart failure in Denmark.
Representing Market Access on the Jardiance®/Heart Failure brand team.
Contributing to the A10 reimbursement reassessment process in relation to heart failure (HF).
Developing local market access strategies and tactical plans maximizing value communication of Jardiance® for HF with key decision makers.
Developing and maintaining relationships with key stakeholders, i.e. Regions (hereunder the regional formulary committee (lægemiddelkomité) of the Capital Region and other regions), Healthcare Committees & Councils (e.g. Medicintilskudsnævnet, Medicinrådet a.o.), Scientific Associations (e.g. Danish Society of Cardiology, Danish Society of GP’s etc.), Patient Organisations (e.g. Heart Association), Other relevant stakeholders.
Leading the collaboration process with clinical pharmacologists and key members of the formulary committees to ensure appropriate listing of Jardiance® in HF on the regional basis lists.
Driving structural initiatives to support patient health outcomes (e.g. helping to progress the implementation of clinical guideline recommendations for heart failure by creating political understanding of the unmet needs of this patient group – hereunder collaborating with scientific and patient organisations in the field of HF).
Supporting the introduction of a structured disease management program and quality parameters in regional monitoring of HF patients in primary care.
Successfully identifying data gaps and driving data generation within the fields of HE and RWE.
Identifying appropriate channels of information and improving the use of multichannel communication in order to improve patient care and prognosis (hereunder co-survey patients about their knowledge and behaviours and provide appropriate information to support patients in their efforts to improve own prognosis and quality of life)
Providing training to Brand Teams and other key stakeholders, to ensure solid understanding of local payer markets and emerging stakeholders in the reimbursement area and determine appropriate responses to elevate patient care.
Key success criteria:
Ensure reimbursement of Jardiance® in heart failure.
Establish clear overview of gaps in the care of HF patients driven by clinical and RW evidence.
Execute initiatives and engage relevant stakeholders to drive the successful implementation of a structured disease management program and/or quality parameter for disease monitoring of HF patients in order to close care-gaps and improve patient prognosis.
Preferably degree at M.Sc.-level within Health Science, Economics, Nursing or other relevant background.
English or Danish fluently in speech and writing.
Ideal experience and competencies:
3+ years of experience from the Danish regional payer system generated from the pharmaceutical industry and/or Danish regional/national payers (e.g. Medicinrådet, Lægemiddelkommitéer etc.) and/or national policy makers (e.g. Sundhedsministeriet).
Established network with regional payers - particularly the Capital Region, preferably also including clinical KOLs in heart failure/cardiology.
Successful experience and clear preference for communicating and collaborating with customers and KOLs.
Strong ability to identify data gaps and drive data generation within the fields of HE and RWE in collaboration with customers.
Strong ability to communicate clinical, economic, and RW evidence in order to engage with stakeholders and advocate patient care.
Able to identify and communicate central issues in a clear, fluent, and precise manner to different stakeholders. Able to keep the recipients’ attention and is attentive to the needs of others when communicating.
Collaborates and works well with others with a vision to obtain overall team objectives. Is involving and supporting team members, and shares information. Possesses a good sense of humor.
Is proactive and able to inspire others. Self-driven with a “get the work done” approach. Starts up actions on own initiative. Has an urge to move things forward in the right direction and to make things happen.
Works systematically and effectively organizes work and effort. Is methodical in one's performance and holds on to commenced tasks and projects.
Results-oriented problem solver
Focus on action, activities, and results. Is able to develop and implement innovative solutions based on customer needs. Is able to continue working on a specific problem, viewpoint, or action plan until a result has been achieved or it is determined that an alternative approach is needed.
Has a profound ambition to grow – professionally and personally.
Ability to negotiate
Prepares and plans negotiations. Is able to present views and suggestions in a constructive manner while being attentive to the opponent's situation and expectations. Is able to influence other people's attitudes and opinions, and achieve consensus regarding suggestions, plans, and ideas. Sticks to own views and achieves results.
Has a logical mind-set and is able to differentiate between key, less important, and irrelevant areas. Makes sensible decisions on the basis of available information while being able to effectively identify information gaps. Is able to get an overview of a specific situation and at the same time work detailed with a problem.
Multi-tasking and project leadership
Navigates well in multi-task environments and makes sure that co-workers have a clear understanding of the direction of the tasks. Takes action and organizes resources toward successful execution of the tasks. Drives projects forward to reach pivotal objectives – makes things happen and follows through.
For further information:
EA & Research Associate